Breast Cancer Patients and Chromosomal Radiosensitivity
Author Information
Author(s): Baeyens A, Thierens H, Claes K, Poppe B, Messiaen L, De Ridder L, Vral A
Primary Institution: University of Gent
Hypothesis
Breast cancer patients with a known or putative genetic predisposition have higher chromosomal radiosensitivity compared to healthy women.
Conclusion
Breast cancer patients with a genetic predisposition are more radiosensitive to ionizing radiation than healthy individuals.
Supporting Evidence
- 43% of breast cancer patients were found to be radiosensitive using the G2 assay.
- 45% of patients were radiosensitive with the high dose rate micronucleus assay.
- 61% of patients were radiosensitive with the low dose rate micronucleus assay.
- The group of young breast cancer patients without family history showed the highest radiosensitivity.
Takeaway
Some breast cancer patients are more sensitive to radiation than healthy people, which might be linked to their genetics.
Methodology
The study used the G2 and micronucleus assays to assess chromosomal radiosensitivity in breast cancer patients and healthy controls.
Potential Biases
Potential selection bias due to the focus on patients with a family history or early onset of breast cancer.
Limitations
The study's findings may not apply to all breast cancer patients, as it focused on those with a known or putative genetic predisposition.
Participant Demographics
62 breast cancer patients aged 29-69 and 60 healthy women aged 23-60.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website